Unilever Bulls Eye Emerging Market Recovery Before Thursday's Print

UL heads into Thursday's Q3 results with investors positioned in a way that suggests comfort rather than anxiety, yet the stock's recent history warns against complacency.

The lending market tells a relaxed story. Borrow availability is extremely loose, with roughly 13 shares available for every one already borrowed, a level that has barely tightened over the past year. Borrowing costs are negligible at 0.44%, down sharply on the week. Short interest itself is minimal at around 4.9 million shares, and with nearly two million shares per day required to cover, the implied days-to-cover sits well under two days. Nothing in the lending data suggests a crowded short position. Options positioning reinforces the same message: the put/call ratio of 0.80 is almost exactly in line with its 20-day average, with a z-score near zero. Neither bulls nor bears are loading up ahead of the print.

The more substantive debate is about whether Unilever's restructuring is translating into durable volume growth. Bulls point to a stock that has climbed 5% over the past month to $65.15, recovering ground after a period of persistent underperformance against peers including Nestlé and Procter & Gamble. The business has been shedding slower-growth brands and leaning harder into emerging markets, and the bullish view is that pricing gains are increasingly complemented by real volume recovery. Bears counter that the EPS surprise factor score of 33 places Unilever below the middle of its universe on the consistency of beating estimates, and the analyst recommendation differential score of just 4 out of 100 implies the Street's conviction on the bull case remains weak. The PE of 17.5x and EV/EBITDA of 12.3x have both compressed modestly over the past month, but at a price-to-book above 7.8x the stock leaves little margin for a disappointing volume number.

One institutional data point worth noting: BlackRock added 6.7 million shares in the most recent quarter to hold 8.6% of the company, and T. Rowe Price added 1.8 million. The Leverhulme Trade Charities Trust, a long-standing structural holder, trimmed by 11.7 million shares in the same period. The ORTEX short score of 29 places Unilever in the 93rd percentile for low short-selling pressure, reinforcing that the dominant question into Thursday is not about short covering but about whether the underlying business can justify a stock trading near a five-year multiple high.

The July print delivered a 7.5% single-day gain. Thursday's release will test whether that reaction was the start of a re-rating or a one-quarter reprieve in a longer story about whether Unilever's portfolio simplification is generating the volume momentum the valuation now implies.